pirfenidone has been researched along with s 1743 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benesic, A; Gerbes, AL; Jalal, K | 1 |
| Ahir, M; Bonnen, MD; Ebrahimpour, A; Eissa, NT; Ghebre, YT; Jegga, AG; Montesi, SB; Raghu, G; Wang, M | 1 |
2 other study(ies) available for pirfenidone and s 1743
| Article | Year |
|---|---|
Acute Liver Failure During Pirfenidone Treatment Triggered by Co-Medication With Esomeprazole.
Topics: Aged; Drug Combinations; Esomeprazole; Humans; Liver Failure, Acute; Male; Pyridones | 2019 |
Combination of esomeprazole and pirfenidone enhances antifibrotic efficacy in vitro and in a mouse model of TGFβ-induced lung fibrosis.
Topics: Animals; Disease Models, Animal; Esomeprazole; Idiopathic Pulmonary Fibrosis; Mice; Prospective Studies; Proton Pump Inhibitors; Retrospective Studies; Transforming Growth Factor beta | 2022 |